(Circulation. 1995;92:290-295.)
© 1995 American Heart Association, Inc.
Articles |
Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation
From Département de médecine sociale et préventive, Faculté de Médecine, Université de Montréal, Montreal, Quebec, Canada (J.F., J.L.), and the Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, Montreal, Quebec, Canada (J.F., S.L.-C., J.D.).
Correspondence to Dr S. Lussier-Cacan, Hyperlipidemia and Atherosclerosis Research Group, Clinical Research Institute of Montreal, 110 Pine Ave W, Montreal, Quebec, Canada H2W 1R7.
Background Familial hypercholesterolemia (FH), an autosomal codominant disease, is characterized by high levels of LDL cholesterol and a high incidence of coronary artery disease (CAD). To date, genetic heterogeneity has hindered the proper assessment of the relation between risk factors and CAD in FH patients.
Methods and Results We studied the association between CAD and common risk factors in a sample of 263 French Canadian FH patients (147 women, 116 men) carrying the same >10-kb deletion of the LDL receptor gene. Thirty-five women and 54 men had CAD. The mean age of onset of CAD was 45.6±12.7 years in women and 38.8±9.4 years in men. Multiple logistic regression analyses were performed to test the association between CAD and age, tendon xanthomas, cigarette smoking, hypertension, diabetes mellitus, apolipoprotein E polymorphism, total plasma cholesterol, triglycerides, VLDL cholesterol, LDL cholesterol, HDL cholesterol, and lipoprotein(a) [Lp(a)]. In FH women, significant multivariate predictors were age (odds ratio, 1.10 for 1 year; P<.0001), VLDL cholesterol (odds ratio, 3.85 for 1 natural log unit; P<.002), and LDL cholesterol (odds ratio, 1.42 for 1 mmol/L; P<.02). In FH men, age (odds ratio, 1.08 for 1 year; P<.0001) and HDL cholesterol (odds ratio, 0.14 for 1 mmol/L; P=.05) were significant predictors of disease. Lp(a) was not a significant predictor in univariate or multivariate analyses.
Conclusions This study suggests that increased risk of CAD in FH is not solely due to elevated LDL cholesterol levels and demonstrates a sex-specific lipoprotein influence on CAD in a large sample of FH patients carrying the same LDL receptor gene defect.
Key Words: hypercholesterolemia • coronary disease • risk factors
This article has been cited by other articles:
 |
|
 |
|
  M. L. E. MacDonald, R. R. Singaraja, N. Bissada, P. Ruddle, R. Watts, J. M. Karasinska, W. T. Gibson, C. Fievet, J. E. Vance, B. Staels, et al. Absence of stearoyl-CoA desaturase-1 ameliorates features of the metabolic syndrome in LDLR-deficient mice J. Lipid Res., January 1, 2008; 49(1): 217 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Junyent, M. Cofan, I. Nunez, R. Gilabert, D. Zambon, and E. Ros Influence of HDL Cholesterol on Preclinical Carotid Atherosclerosis in Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1107 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Holmes, B. A. Schick, K. H. Humphries, and J. Frohlich Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia Clin. Chem., November 1, 2005; 51(11): 2067 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Junyent, R. Gilabert, D. Zambon, I. Nunez, M. Vela, F. Civeira, M. Pocovi, and E. Ros The Use of Achilles Tendon Sonography to Distinguish Familial Hypercholesterolemia from Other Genetic Dyslipidemias Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2203 - 2208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Civeira, S. Castillo, R. Alonso, E. Merino-Ibarra, A. Cenarro, M. Artied, P. Martin-Fuentes, E. Ros, M. Pocovi, P. Mata, et al. Tendon Xanthomas in Familial Hypercholesterolemia Are Associated With Cardiovascular Risk Independently of the Low-Density Lipoprotein Receptor Gene Mutation Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1960 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C.M. Jansen, E. S. van Aalst-Cohen, M. W.T. Tanck, S. Cheng, M. R. Fontecha, J. Li, J. C. Defesche, and J. J.P. Kastelein Genetic Determinants of Cardiovascular Disease Risk in Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1475 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H A W Neil, V Seagroatt, D J Betteridge, M P Cooper, P N Durrington, J P Miller, M Seed, R P Naoumova, G R Thompson, R Huxley, et al. Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia Heart, December 1, 2004; 90(12): 1431 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Slyper What Vascular Ultrasound Testing Has Revealed about Pediatric Atherogenesis, and a Potential Clinical Role for Ultrasound in Pediatric Risk Assessment J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3089 - 3095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Cenarro, M Artieda, S Castillo, P Mozas, G Reyes, D Tejedor, R Alonso, P Mata, M Pocovi, and F Civeira A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia J. Med. Genet., March 1, 2003; 40(3): 163 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Chaves, J. T. Real, A. B. Garcia-Garcia, M. Civera, M. E. Armengod, J. F. Ascaso, and R. Carmena Genetic Diagnosis of Familial Hypercholesterolemia in a South European Outbreed Population: Influence of Low-Density Lipoprotein (LDL) Receptor Gene Mutations on Treatment Response to Simvastatin in Total, LDL, and High-Density Lipoprotein Cholesterol J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4926 - 4932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.T Real, F.J Chaves, I Martinez-Uso, A.B Garcia-Garcia, J.F Ascaso, and R Carmena Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia Eur. Heart J., March 2, 2001; 22(6): 465 - 471. [Abstract] [PDF]
|
|
|
|
 |
|
 A. S. Wierzbicki, M. Lambert-Hammill, P. J. Lumb, and M. A. Crook Renin-Angiotensin System Polymorphisms and Coronary Events in Familial Hypercholesterolemia Hypertension, November 1, 2000; 36(5): 808 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bertolini, A. Cantafora, M. Averna, C. Cortese, C. Motti, S. Martini, G. Pes, A. Postiglione, C. Stefanutti, I. Blotta, et al. Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): e41 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Vuorio, H. Gylling, H. Turtola, K. Kontula, P. Ketonen, and T. A. Miettinen Stanol Ester Margarine Alone and With Simvastatin Lowers Serum Cholesterol in Families With Familial Hypercholesterolemia Caused by the FH-North Karelia Mutation Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 500 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H.-J. Schmidt, M. Stuhrmann, R. Shamburek, C. K. Schewe, M. Ebhardt, L. A. Zech, C. Büttner, M. Wendt, U. Beisiegel, H. B. Brewer, et al. Delayed Low Density Lipoprotein (LDL) Catabolism Despite a Functional Intact LDL-Apolipoprotein B Particle and LDL-Receptor in a Subject with Clinical Homozygous Familial Hypercholesterolemia J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2167 - 2174. [Abstract] [Full Text]
|
|
|
|
|
|
A. F. Vuorio, H. Turtola, K.-M. Piilahti, P. Repo, T. Kanninen, and K. Kontula Familial Hypercholesterolemia in the Finnish North Karelia : A Molecular, Clinical, and Genealogical Study Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3127 - 3138. [Abstract] [Full Text]
|
|
|
|
|
|
S. Tonstad, O. Joakimsen, E. Stensland-Bugge, T. P. Leren, L. Ose, D. Russell, and K. H. Bonaa Risk Factors Related to Carotid Intima-Media Thickness and Plaque in Children With Familial Hypercholesterolemia and Control Subjects Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 984 - 991. [Abstract] [Full Text]
|
|
|
|
|
|
D. Kardassis, M. Laccotripe, I. Talianidis, and V. Zannis Transcriptional Regulation of the Genes Involved in Lipoprotein Transport : The Role of Proximal Promoters and Long-range Regulatory Elements and Factors in Apolipoprotein Gene Regulation Hypertension, April 1, 1996; 27(4): 980 - 1008. [Full Text]
|
|
|
|
|
|
R. Carmena, S. Lussier-Cacan, M. Roy, A. Minnich, A. Lingenhel, F. Kronenberg, and J. Davignon Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 129 - 136. [Abstract] [Full Text]
|
|